AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
AYTU BIOPHARMA, INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 22, 2026
$1.96−0.08 (-3.92%)
Close on Oct 19, 2026
- Market cap
- $37.82M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Aytu Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Dec 10, 2026 | Oct 22, 2026 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2026 | Sep 22, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2026 | Sep 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 25, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Apr 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 20, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 10, 2025 | Oct 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2025 | Sep 23, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2025 | Sep 23, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 21, 2025 | May 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 21, 2025 | Mar 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 12, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2025 | Feb 12, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2024 | Dec 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 1, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2024 | Sep 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2024 | Sep 26, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 26, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 18, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2024 | May 10, 2024 | SEC EDGAR |